- Daniel Brennan appointed to Vertex board on October 20, 2026.
Vertex Pharmaceuticals appointed Daniel Brennan to its board of directors, increasing board size from 10 to 11. Brennan, former EVP and CFO of Boston Scientific, received a $400,000 restricted stock unit award vesting in October 2027 and joined the Audit and Finance Committee.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.